Coalition Tells Congress: Say “No” to Price Controls

Today, a large coalition of think tanks sent a letter to members of Congress opposing efforts to place artificial prices on prescription drugs. The letter explains that such price controls would lead to drug shortages, impede investment and innovation, and lead to worse outcomes for patients.

The letter is available online.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin